Long-term real-world (RW) outcomes in patients with advanced melanoma (MEL) treated with ipilimumab (IPI) and non-IPI therapies: IMAGE study
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Oxford University Press
2019
|
Summary: |
---|